遗弃 发表于 2025-3-23 09:48:58
http://reply.papertrans.cn/39/3830/382944/382944_11.pngdapper 发表于 2025-3-23 16:25:17
Die Aussichten von Zwanglaufkesseln with mastectomy and axillary dissection. The development of pharmacologic hormonal therapy, more effective cytotoxic chemotherapy, and targeted HER2 therapy has improved survival for women with the most common types of breast cancer as well as less common but highly aggressive cancers. The developmIntroduction 发表于 2025-3-23 21:38:48
http://reply.papertrans.cn/39/3830/382944/382944_13.pngCamouflage 发表于 2025-3-23 23:28:04
http://reply.papertrans.cn/39/3830/382944/382944_14.png粘连 发表于 2025-3-24 02:31:28
Living Between Sickness and Health: Where Is the Human Genome Leading Us?,velopment. In other disease states, research is only just beginning to identify genetic loci that could be responsible for development. This chapter is meant to answer the following question: how much of our health can we control, and what role does genetic variation play in disease development?foreign 发表于 2025-3-24 06:58:25
The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases,nsion, and diabetes. Contrasting this is the “prudent” dietary pattern characterized by increased fruit, vegetables, poultry, fish, whole grains, and legumes which had improved biomarker profiles of the aforementioned diseases. Similar to the “Western” pattern is a diet with . saturated fat/high simglucagon 发表于 2025-3-24 14:27:38
http://reply.papertrans.cn/39/3830/382944/382944_17.png失望未来 发表于 2025-3-24 16:05:44
http://reply.papertrans.cn/39/3830/382944/382944_18.pngHot-Flash 发表于 2025-3-24 19:40:13
Essentials of Genomics in the Continuum of Translational Research,y which new research discoveries are translated into clinical and useful genomic testing so that a framework for personalized medicine can be developed. This chapter focuses mainly on the continuum of an evidence-based framework for multidisciplinary translational research in genomics along with sevIngredient 发表于 2025-3-25 01:45:34
Charting a Course for Genomic Medicine from Base Pair to Bedside,beling describing risk for adverse drug events, genotype-specific dosing, and/or variations in pharmacokinetic and pharmacodynamic parameters. For a select group of medications, such as codeine and clopidogrel, pharmacogenomic information may even be highlighted in a black box warning further emphas